Introduction: Cardiovascular diseases are the leading cause of mortality in type 2
diabetics patients. Our work aimed to assess the level of control of type 2
diabetes and associated cardiovascular risk factors. Patients and study
method: This was an observational cross-sectional study of type 2 diabetics
patients. The parameters studied were: sociodemographic data, lifestyle,
anthropometric data, levels of control of diabetes by the level of HbA1C, blood
pressure measured at the office and cholesterol. Results: 326 type 2
diabetics patients were collected. The sex-ratio was 0.35. The average age of
the patients was 58 ±11
years. A physical inactivity remained present in 79 patients (24.23%), 2
patients (0.61%) continued to smoke. The prevalence of obesity was 21.16% (n =
69) or 25% of women and 10.4% of men (p = 0.01). Abdominal obesity was observed
in 151 patients (46.31%), 139 of whom were female and 12 male (p = 0.001).
Diabetes was sufficiently controlled in 65.34% of patients (n = 213) while cholesterolemia
and hypertension were controlled in 33.44% and 8.33% of patients respectively. Conclusion: Type 2 diabetes was frequently associated with other cardiovascular risk
factors. Control of diabetes and these factors was insufficient. Therapeutic education
of type 2 diabetics patients needed to be improved.
References
[1]
Nations Unies (2022) L’Afrique est la première région du monde pour le diabète non diagnostiqué, selon l’OMS. https://news.un.org/fr/story/2022/11/1129822#
[2]
Agence nationale de la démographie et de la statistique du Sénégal.
https://www.ansd.sn/sites/default/files/2022-11/1-SES-2017-2018_Etat-structure-population_0.pdf
[3]
Mondial, B. (2021) Nouvelle classification des pays en fonction de leur revenu 2020-2021.
https://blogs.worldbank.org/fr/opendata/nouvelle-classification-des-pays-en-fonction-de-leur-revenu-2020-2021
[4]
Carre, F. (2007) Activité physique et prévention cardio-vasculaire. Cardiologie et maladies vasculaires. Société Francaise de Cardiologie. Masson, Paris, 4, 302-309.
[5]
Consultation OMS sur l’obésité (2003) Obésité: Prévention et prise en charge de l’épidémie mondiale: Rapport d’une consultation de l’OMS. OMS, Série de rapports techniques. Genève. 894.
http://apps.who.int/iris/bitstream/10665/42734/1/WHO_TRS_894_fre.pdf
[6]
World Health Organization, International Society of Hypertension (1999) Guidelines for the Management of Hypertension. Journal Hypertension, 17, 151-183.
https://doi.org/10.1097/00004872-199917020-00001
[7]
Cosentino, F., Grant, P.J., Aboyans, V., et al. (2020) 2019 ESC Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases Developed in Collaboration with the EASD. European Heart Journal, 41, 255-323.
[8]
Group IDFW (2017) IDF Clinical Practice Recommendations for Managing Type 2 Diabetes in Primary Care International Diabetes Federation—2017.
http://www.idf.org/managing-type2-diabetes.IDF
[9]
Yaméogo, N.V., Mbaye, A., Ndour, M., et al. (2012) Controle du risque cardio- vasculaire chez les diabétiques de type 2 noirs africains au Sénégal. Cardiovascular Journal of Africa, 23, 270-272.
https://doi.org/10.5830/CVJA-2011-040
[10]
Diop, S.N., Wade, A., Lokrou, A., et al. (2013) Management of Type 2 Diabetes in Clinical Practices in Sub-Saharan Africa: Results of the AMAR-AFO Study in Senegal and Ivory Cost. Médecine des Maladies Métaboliques, 7, 363-367.
https://doi.org/10.1016/S0168-8227(14)70205-0
[11]
Ndour Mbaye, M., Sarr, A., Diop, S.N., et al. (2011) Diab Care Sénégal: Une enquête sur la prise en charge du diabète au Sénégal. Médecine des Maladies Métaboliques, 5, 85-89. https://doi.org/10.1016/S1957-2557(11)70200-0
[12]
McFarlane, S.I., Jacober, S.J., Winer, N., et al. (2002) Control of Cardiovascular Risk Factors in Patients with Diabetes and Hypertension at Urban Academic Medical Centers. Diabetes Care, 25, 718-723. https://doi.org/10.2337/diacare.25.4.718
[13]
Charpentier, G., Genès, N., Vaur, L., et al. (2003) Control of Diabetes and Cardiovascular Risk Factors in Patients with Type 2 Diabetes: A Nationwide French Survey. Diabetes & Metabolism, 29, 152-158.
https://doi.org/10.1016/S1262-3636(07)70022-8
[14]
Ray, K.K., Seshasai, S.R.K., Wijesuriya, S., et al. (2009) Effect of Intensive Control of Glucose on Cardiovascular Outcomes and Death in Patients with Diabetes Mellitus: A Meta-Analysis of Randomised Controlled Trials. The Lancet, 373, 1765-1772.
https://doi.org/10.1016/S0140-6736(09)60697-8
[15]
Yusuf, P.S., Hawken, S., Ounpuu, S., et al. (2004) Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the INTERHEART Study): Case-Control Study. The Lancet, 364, 937-952.
https://doi.org/10.1016/S0140-6736(04)17018-9
[16]
Belhadj, M., Malek, R., Boudiba, A., et al. (2010) DiabCare Algérie: DiabCare Algeria. Médecine des Maladies Métaboliques, 4, 88-92.
https://doi.org/10.1016/S1957-2557(10)70020-1
[17]
Tiéno, H., Bouda, M., Ouédraogo, D.D., et al. (2010) Observance to Antidiabetic Treatment in a Developing Country: The Case in Burkina Faso (Sub-Saharan Africa). Médecine des Maladies Métaboliques, 4, 207-211.
https://doi.org/10.1016/S1957-2557(10)70046-8
[18]
Abodo, J., Oka, F., Ankotché, A., et al. (2013) Mesure de l’observance therapeutique chez les patients diabetiques suivis a l’hopital militaire d’Abidjan. Guinée Médicale, No. 81, 4-9.
[19]
Oulad Sayad, N., Bertal Filali, K. and Diouri, A. (2009) Profil cardio-vasculaire des diabétiques de l’hopital de jour du CHU Mohammed VI: A propos de 80 cas. Diabetes & Metabolism, 35, 43. https://doi.org/10.1016/S1262-3636(09)71861-0
